1. Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial. Issue 5 (May 2015) Authors: Eggermont, Alexander M M; Chiarion-Sileni, Vanna; Grob, Jean-Jacques; Dummer, Reinhard; Wolchok, Jedd D; Schmidt, Henrik; Hamid, Omid; Robert, Caroline; Ascierto, Paolo A; Richards, Jon M; Lebbé, Céleste; Ferraresi, Virginia; Smylie, Michael; Weber, Jeffrey S; Maio, Michele; Konto, Cyril; Hoos, A... Journal: Lancet oncology Issue: Volume 16:Issue 5(2015:May) Page Start: 522 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. An unusual case of primary cutaneous Ewing sarcoma in an adult. (3rd March 2016) Authors: Barreau, Morgane; Chevallier, Jean‐Marc; Pontoizeau, Julien; Bazille, Céline; Lebbé, Céleste; Verneuil, Laurence; Dompmartin, Anne Journal: International journal of dermatology Issue: Volume 55:Number 8(2016) Page Start: 906 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Anti-PD1-induced collagenous colitis in a melanoma patient. Issue 3 (June 2016) Authors: Baroudjian, Barouyr; Lourenco, Nelson; Pagès, Cécile; Chami, Ichrak; Maillet, Marianne; Bertheau, Philippe; Bagot, Martine; Gornet, Jean-Marc; Lebbé, Céleste; Allez, Matthieu Journal: Melanoma research Issue: Volume 26:Issue 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Anti-programmed cell death protein 1 tolerance and efficacy after ipilimumab immunotherapy: observational study of 39 patients. Issue 2 (April 2017) Authors: Amode, Reyhan; Baroudjian, Barouyr; Kowal, Anita; Jebali, Majdi; Allayous, Clara; Bagot, Martine; Madjlessi, Nika; Roux, Jennifer; Viguier, Manuelle; Basset Seguin, Nicole; Porcher, Raphaël; Pagès, Cécile; Lebbé, Céleste Journal: Melanoma research Issue: Volume 27:Issue 2(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Atypical severe immune-related adverse effects resulting from sequenced immunotherapy in melanoma. Issue 2 (April 2015) Authors: Danlos, François-Xavier; Pagès, Cécile; Roux, Jennifer; Jebali, Majdi; Gornet, Jean-Marc; Bagot, Martine; Lebbé, Céleste Journal: Melanoma research Issue: Volume 25:Issue 2(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial. Issue 10 (October 2016) Authors: Kaufman, Howard L; Russell, Jeffery; Hamid, Omid; Bhatia, Shailender; Terheyden, Patrick; D'Angelo, Sandra P; Shih, Kent C; Lebbé, Céleste; Linette, Gerald P; Milella, Michele; Brownell, Isaac; Lewis, Karl D; Lorch, Jochen H; Chin, Kevin; Mahnke, Lisa; von Heydebreck, Anja; Cuillerot, Jean-Marie;... Journal: Lancet oncology Issue: Volume 17:Issue 10(2016:Oct.) Page Start: 1374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Checkpoint inhibitor treatment induces an increase in HbA1c in nondiabetic patients. Issue 3 (June 2019) Authors: Gauci, Marie-Léa; Boudou, Philippe; Squara, Pierre-Alexandre; Delyon, Julie; Allayous, Clara; Mourah, Samia; Resche-Rigon, Matthieu; Lebbé, Céleste; Baroudjian, Barouyr; Gautier, Jean-François Journal: Melanoma research Issue: Volume 29:Issue 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Cochleovestibular toxicity induced by immune checkpoint inhibition: a case series. (August 2019) Authors: Lemasson, Juliette; Cuzzubbo, Stefania; Doucet, Ludovic; Gounant, Valérie; Baroudjian, Barouyr; Herms, Florian; Carpentier, Antoine F.; Lebbé, Céleste; Vitaux, Hélène; Hautefort, Charlotte; Delyon, Julie Journal: European journal of cancer Issue: Volume 117(2019) Page Start: 116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. CRTC1-TRIM11 Fusion in a Case of Metastatic Clear Cell Sarcoma: Are CRTC1-TRIM11 Fusion-bearing Tumors Melanocytomas or Clear Cell Sarcomas?. (June 2019) Authors: Bontoux, Christophe; Baroudjian, Barouyr; Le Maignan, Christine; Vercellino, Laetitia; Farges, Cécile; Guillemot, Delphine; Pierron, Gaëlle; Lebbé, Céleste; Battistella, Maxime Journal: American journal of surgical pathology Issue: Volume 43:Number 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial. Issue 7 (July 2017) Authors: Davies, Michael A; Saiag, Philippe; Robert, Caroline; Grob, Jean-Jacques; Flaherty, Keith T; Arance, Ana; Chiarion-Sileni, Vanna; Thomas, Luc; Lesimple, Thierry; Mortier, Laurent; Moschos, Stergios J; Hogg, David; Márquez-Rodas, Iván; Del Vecchio, Michele; Lebbé, Céleste; Meyer, Nicolas; Zhang, Y... Journal: Lancet oncology Issue: Volume 18:Issue 7(2017:Jul.) Page Start: 863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗